Bio Green Med Solution (BGMS) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.80 Bn | 133.95 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.79 Bn | 1.37 Bn |
| 4 | Moderna | 57.34 Bn | 52.20 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.46 Bn | 44.46 Bn | - |
| 6 | BeOne Medicines | 40.34 Bn | 35.24 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.15 Bn | 27.32 Bn | - |
| 9 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.01 Mn | 1.22 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -95.85% |
| Mar 31, 2026 | 97.87% |
| Dec 31, 2025 | -306.31% |
| Sep 30, 2025 | -87.07% |
| Jun 30, 2025 | -1,551.85% |
| Mar 31, 2025 | 97.35% |
| Dec 31, 2024 | -55.95% |
| Sep 30, 2024 | 39.91% |
| Jun 30, 2024 | -10.56% |
| Mar 31, 2024 | 44.63% |
| Dec 31, 2023 | 12.51% |
| Sep 30, 2023 | -10.62% |
| Jun 30, 2023 | 6.08% |
| Mar 31, 2023 | 21.62% |
| Dec 31, 2022 | -42.32% |
| Sep 30, 2022 | -13.47% |
| Jun 30, 2022 | -11.23% |
| Mar 31, 2022 | -145.54% |
| Dec 31, 2021 | 236.79% |
| Sep 30, 2021 | -28.94% |